| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 1004558-41-1 | 7-Chloro-1H-indole-1-carboxylic acid 1,1-dimethylethyl ester | C13H14ClNO2 |
| 1004643-64-4 | 1-(Difluoromethyl)-5-methyl-1H-pyrazole-3-carboxylic acid | C6H6F2N2O2 |
| 1004997-73-2 | 2-(Aminomethyl)-4-bromoaniline dihydrochloride | C7H11BrCl2N2 |
| 1005009-98-2 | 6-Methylaminopyridine-3-boronic acid pinacol ester;N-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine; N-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-ylamine | C12H19BN2O2 |
| 1005193-64-5 | (5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]cyclopentyl]-N-ethyl-5-heptenamide | C25H34F3NO5 |
| 1005196-61-1 | Methyl 4-chloropyrrolo[2,1-f][1,2,4]triazine-6-carboxylate;4-Chloropyrrolo[2,1-f][1,2,4]triazine-6-carboxylic acid methyl ester | C8H6ClN3O2 |
| 1005206-16-5 | 7H-Pyrrolo[2,3-d]pyrimidine-4-carbonitrile | C7H4N4 |
| 1005206-25-6 | 4-Trifluoromethylthiophenylboronic acid pinacol ester;4,4,5,5-Tetramethyl-2-[4-[(trifluoromethyl)thio]phenyl]-1,3,2-dioxaborolane | C13H16BF3O2S |
| 1005207-32-8 | [4-(Benzylthio)phenyl]boronic acid | C13H13BO2S |
| 1005209-42-6 | Ethyl 6-bromopyrazolo[1,5-a]pyrimidine-2-carboxylate;6-Bromopyrazolo[1,5-a]pyrimidine-2-carboxylic acid ethyl ester | C9H8BrN3O2 |
| 1005209-44-8 | 6-Chloro-pyrazolo[1,5-a]pyrimidine-2-carboxylic acid ethyl ester;Ethyl 6-chloropyrazolo[1,5-a]pyrimidine-2-carboxylate | C9H8ClN3O2 |
| 1005264-47-0 | 4-{8-[(3,4-Dimethylphenyl)sulfamoyl]-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-4-yl}benzoic acid | C27H26N2O4S |
| 1005291-43-9 | 2-Bromo-5-fluoroisonicotinaldehyde;2-Bromo-5-fluoro-4-pyridinecarboxaldehyde | C6H3BrFNO |
| 1005334-57-5 | 3-[[[3-[4-[(Methylsulfonyl)amino]phenyl]-4-oxo-4H-chromen-7-yl]oxy]methyl]benzoic acid;CVT 10216; CVT 10216; GS 455534 | C24H19NO7S |
| 1005342-46-0 | LCL 161;(2S)-N-[(1S)-1-Cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)-2-thiazolyl]-1-pyrrolidinyl]-2-oxoethyl]-2-(methylamino)-propanamide | C26H33FN4O3S |
| 1005342-47-1 | (4-Fluorophenyl)[5-[(2S)-1-[N-methyl-L-alanyl-(2S)-2-cyclohexylglycyl]-2-pyrrolidinyl]-3-pyridinyl]methanone | C28H35FN4O3 |
| 1005342-78-8 | (2S)-2-[4-(4-Fluorobenzoyl)-2-thiazolyl]-1-pyrrolidinecarboxylic acid 1,1-dimethylethyl ester | C19H21FN2O3S |
| 1005450-55-4 | N-[1-(R)-(1-Naphthyl)ethyl]-3-[3-trifluoromethylphenyl]propanamide | C22H20F3NO |
| 1005474-88-3 | 5-Fluoro-6-methylpyridine-2-carboxylic acid;5-Fluoro-6-methyl-2-pyridinecarboxylic acid | C7H6FNO2 |
| 1005491-05-3 | Tirasemtiv;1-(1-Ethylpropyl)-6-ethynyl-1,3-dihydro-2H-imidazo[4,5-b]pyrazin-2-one; CK 2017357 | C12H14N4O |
| 1005498-91-8 | 4-Aminotetrahydro-2H-pyran acetate;Tetrahydro-2H-pyran-4-amine acetate | C5H11NO.C2H4O2 |
| 1005504-62-0 | 5-[[1-(2,6-Dichlorobenzyl)piperidin-4-yl]methoxy]quinazoline-2,4-diamine | C21H23Cl2N5O |
| 1005756-81-9 | 2-(Tetrahydro-2H-pyran-2-yl)ethanamine hydrochloride | C7H15NO.HCl |
| 1005771-04-9 | 1,3-Dibromo-7-tert-butylpyrene | C20H16Br2 |
| 1005785-45-4 | 6-Chloroimidazo[1,2-a]pyridin-2-amine | C7H6ClN3 |
| 1005785-65-8 | (6-Chloroimidazo[1,2-b]pyridazin-2-yl)carbamic acid ethyl ester | C9H9ClN4O2 |
| 1006036-87-8 | MK-2894;4-[1-[[[2,5-Dimethyl-4-[[4-(trifluoromethyl)phenyl]methyl]-3-thienyl]carbonyl]amino]cyclopropyl]benzoic acid | C25H22F3NO3S |
| 1006036-88-9 | MK-2894 Na salt;4-[1-[[[2,5-Dimethyl-4-[[4-(trifluoromethyl)phenyl]methyl]-3-thienyl]carbonyl]amino]cyclopropyl]benzoic acid sodium salt | C25H22F3NO3S.Na |
| 1006062-27-6 | O-Acetyl losartan;2-Butyl-4-chloro-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-methanol 5-acetate | C24H25ClN6O2 |
| 1006335-39-2 | N-(2,3-Dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)-3-(1-ethyl-3-methyl-1H-pyrazol-4-yl)-4,5-dihydro-5-isoxazolecarboxamide;ISPA 28 | C21H24N6O3 |
| 1006376-60-8 | (alphaS)-alpha-(Chloromethyl)-3,4-difluorobenzenemethanol | C8H7ClF2O |
| 1006376-61-9 | (1R,2R)-2-(3,4-Difluorophenyl)cyclopropanecarboxylic acid ethyl ester | C12H12F2O2 |
| 1006376-62-0 | (1R,2R)-2-(3,4-Difluorophenyl)cyclopropanecarboxamide | C10H9F2NO |
| 1006378-06-8 | Gefitinib Impurity 17;4-Methoxy-3-(3-morpholinopropoxy)-2-nitrobenzonitrile | C15H19N3O5 |
| 1006381-03-8 | (4R)-4-Methyl-1,3,2-dioxathiolane 2,2-dioxide;(R)-4-Methyl-1,3,2-dioxathiolane 2,2-dioxide | C3H6O4S |
| 1006436-44-7 | 1-Methyl-3-(trifluoromethyl)-1H-pyrazol-4-amine | C5H6F3N3 |
| 1006614-49-8 | (1R,2S)-rel-2-(3,4-Difluorophenyl)cyclopropanamine | C9H9F2N |
| 1006876-27-2 | N,N-dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinamide | C14H21BN2O3 |
| 1006891-07-1 | 7-Methoxy-3-methyl-6-[2-(quinolin-2-yl)ethoxy]quinazolin-4(3H)-one | C21H19N3O3 |
| 1007089-84-0 | 3-(Chloromethyl)-5-methylpyridine hydrochloride | C7H7N.HCl |
| 1007206-54-3 | 1H-Benzimidazole-5-boronic acid pinacol ester;5-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-1H-benzimidazole; 6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-benzo[d]imidazole | C13H17BN2O2 |
| 1007207-67-1 | [5-[7-Methylsulfonyl-2-(morpholin-4-yl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-yl]amine | C15H19N7O3S |
| 1007207-89-7 | (3-Bromo-4-fluorophenyl)(morpholin-4-yl)methanone | C11H11BrFNO2 |
| 1007219-73-9 | 1-Methyl-1H-indazole-6-carboxylic acid methyl ester | C10H10N2O2 |
| 1007308-74-8 | 7-Fluoro-6-nitro-2,4(1H,3H)-quinazolinedione | C8H4FN3O4 |
| 1007308-75-9 | 2,4-Dichloro-7-fluoro-6-nitroquinazoline | C8H2Cl2FN3O2 |
| 1007311-95-6 | Dicyclohexyl[9-(3-phenylpropyl)-9H-fluoren-9-yl]phosphine tetrafluoroborate | C34H41P.BF4.H |
| 1007311-98-9 | (9-Butyl-9H-fluoren-9-yl)dicyclohexylphosphine tetrafluoroborate | C29H39P.BF4.H |
| 1007358-76-0 | (R)-Ambrisentan;(2R)-2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-diphenylpropanoic acid | C22H22N2O4 |
| 1007455-21-1 | 2-Bromo-4-fluoro-5-methoxybenzoic acid | C8H6BrFO3 |